BLFS BIOLIFE SOLUTIONS INC revenue, earnings and financials
For the quarter ended June 30, 2026, BIOLIFE SOLUTIONS INC reported revenue of $28.5M (up 21.5% from a year earlier), net income of $45.1M and diluted EPS of $0.91; over the last four quarters revenue was $107M and net income $58.0M; for the fiscal year ended December 2025 revenue was $96.2M, up 28.9% on the year before.
BLFS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $96.2M, gross profit $62.1M, operating income −$16.6M, net income −$4.60M (margin -4.8%), EPS −$0.10
- Fiscal year ended Dec 2024: revenue $74.6M, gross profit $50.1M, operating income −$4.48M, net income −$20.2M (margin -27.0%), EPS −$0.44
- Fiscal year ended Dec 2023: revenue $68.0M, gross profit $41.3M, operating income −$17.2M, net income −$68.0M (margin -100.0%), EPS −$1.55
- Fiscal year ended Dec 2022: revenue $76.2M, gross profit n/a, operating income −$5.92M, net income −$140M (margin -183.4%), EPS −$3.25
- Fiscal year ended Dec 2021: revenue $119M, gross profit n/a, operating income −$35.2M, net income −$8.91M (margin -7.5%), EPS −$0.23
BLFS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $28.5M (up 21.5% year over year), net income $45.1M, EPS $0.91
- Quarter ended Mar 31, 2026: revenue $27.5M (up 24.7% year over year), net income $1.19M, EPS $0.02
- Quarter ended Dec 31, 2025 (from the annual report): revenue $22.7M (up 50.0% year over year), net income $11.1M, EPS $0.22
- Quarter ended Sep 30, 2025: revenue $28.1M (up 31.2% year over year), net income $621K, EPS $0.01
- Quarter ended Jun 30, 2025: revenue $23.4M (up 18.9% year over year), net income −$15.8M, EPS −$0.33
- Quarter ended Mar 31, 2025: revenue $22.1M (up 19.6% year over year), net income −$448K, EPS $0.00
- Quarter ended Dec 31, 2024 (from the annual report): revenue $15.1M (up 167.2% year over year), net income $12.5M, EPS $0.27
- Quarter ended Sep 30, 2024: revenue $21.4M (down 9.3% year over year), net income −$1.70M, EPS −$0.04
- Quarter ended Jun 30, 2024: revenue $19.7M (down 32.6% year over year), net income −$20.7M, EPS −$0.45
- Quarter ended Mar 31, 2024: revenue $18.4M (down 51.1% year over year), net income −$10.2M, EPS −$0.22
- Quarter ended Dec 31, 2023 (from the annual report): revenue −$22.5M (up 45.5% year over year), net income −$15.0M, EPS −$0.33
- Quarter ended Sep 30, 2023: revenue $23.6M (down 42.1% year over year), net income −$29.1M, EPS −$0.67
- Quarter ended Jun 30, 2023: revenue $29.2M (down 27.9% year over year), net income −$10.2M, EPS −$0.23
- Quarter ended Mar 31, 2023: revenue $37.7M (up 4.1% year over year), net income −$13.7M, EPS −$0.32
- Quarter ended Dec 31, 2022 (from the annual report): revenue −$41.3M (down 210.6% year over year), net income −$49.2M, EPS n/a
- Quarter ended Sep 30, 2022: revenue $40.7M (up 20.6% year over year), net income −$10.3M, EPS −$0.24
- Quarter ended Jun 30, 2022: revenue $40.5M (up 29.9% year over year), net income −$72.9M, EPS −$1.72
- Quarter ended Mar 31, 2022: revenue $36.2M (up 115.0% year over year), net income −$7.42M, EPS n/a
- Quarter ended Dec 31, 2021 (from the annual report): revenue $37.3M, net income −$15.7M, EPS −$0.39
- Quarter ended Sep 30, 2021: revenue $33.8M, net income $79.0K, EPS $0.00
BLFS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $20.1M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $8.43M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$12.5M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$8.49M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.59M, share buybacks n/a
BLFS balance sheet
- Jun 30, 2026: cash $24.0M, total assets $447M, total liabilities $27.5M, shareholders' equity $420M
- Mar 31, 2026: cash $22.8M, total assets $401M, total liabilities $28.7M, shareholders' equity $372M
- Dec 31, 2025: cash $33.0M, total assets $406M, total liabilities $34.0M, shareholders' equity $372M, long-term debt $0
- Sep 30, 2025: cash $29.5M, total assets $392M, total liabilities $38.3M, shareholders' equity $354M, long-term debt $0
- Jun 30, 2025: cash $31.9M, total assets $387M, total liabilities $40.1M, shareholders' equity $347M, long-term debt $0
- Mar 31, 2025: cash $66.9M, total assets $395M, total liabilities $42.5M, shareholders' equity $353M, long-term debt $2.50M
- Dec 31, 2024: cash $91.5M, total assets $399M, total liabilities $50.6M, shareholders' equity $349M, long-term debt $5.00M
- Sep 30, 2024: cash $24.0M, total assets $382M, total liabilities $56.2M, shareholders' equity $325M, long-term debt $7.82M
What is BLFS's revenue?
BIOLIFE SOLUTIONS INC reported $107M of revenue over its last four quarters, through June 30, 2026.
Is BLFS profitable?
Yes. BIOLIFE SOLUTIONS INC earned $58.0M over the last four quarters.
What is BLFS's EPS?
Diluted earnings per share over the last four quarters were $1.16; $0.91 in the latest quarter.